Therefore, the expression of Ki-67 could be applied to assess tumor proliferation in clinical pathology, and Ki-67 labeling index (the fraction of Ki-67-positive tumor cells by immunohistochemistry) was widely explored for its prognostic value in various tumors including neuroendocrine neoplasms [15]. This evidence concerns the gene MKI67 and neuroendocrine neoplasm.